Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Huhn

Showing results (321-330 of 380) with videos related to

Pageof 38
Sort By:
Open Forum Infectious Diseases|January 18, 2020
Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil FumarateGregory D Huhn, David J Shamblaw, Jean-Guy Baril, et al.
Leukemia Research|June 1, 1994
Overexpression of the Raf-1 proto-oncogene in human myeloid leukemiaC A Schmidt, H Oettle, W D Ludwig, et al.
Transfusion|May 1, 1988
Rh antibodies against the pretransplant red cells following Rh-incompatible bone marrow transplantationM U Heim, M Schleuning, R Eckstein, et al.
Bone Marrow Transplantation|August 1, 1990
Soluble interleukin 2 receptors in patients after bone marrow transplantationW Siegert, O Josimovic-Alasevic, R Schwerdtfeger, et al.
Clinical Pharmacology and Therapeutics|January 1, 1995
Pharmacodynamics of daily subcutaneous recombinant human interleukin-3 in normal volunteersR D Huhn, E J Yurkow, J G Kuhn, et al.
Experimental Hematology|December 1, 1993
Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cellsI G Schmidt-Wolf, P Lefterova, B A Mehta, et al.
Blut|March 1, 1988
German-Austrian multicenter trial for aggressive non-Hodgkin lymphomas: COP-BLAM/IMVP-16 chemotherapy with randomized adjuvant radiotherapyH H Gerhartz, E Thiel, G Brittinger, et al.
The Journal of Organic Chemistry|January 27, 2007
Synthesis of pyrazolo[1,5-alpha]pyrimidinone regioisomersLori K Gavrin, Arthur Lee, Brian A Provencher, et al.
British Journal of Haematology|October 16, 1999
Efficacy and toxicity of IFN-alpha2b combined with cytarabine in chronic myelogenous leukaemiaM Lindauer, D Domkin, H Döhner, et al.
Blood|February 7, 1998
Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemiasM Schmidt, S Nagel, J Proba, et al.
Pageof 38

Showing results (321-330 of 380) with videos related to

Sort By:
Pageof 38
Open Forum Infectious Diseases|January 18, 2020
Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil FumarateGregory D Huhn, David J Shamblaw, Jean-Guy Baril, et al.
Leukemia Research|June 1, 1994
Overexpression of the Raf-1 proto-oncogene in human myeloid leukemiaC A Schmidt, H Oettle, W D Ludwig, et al.
Transfusion|May 1, 1988
Rh antibodies against the pretransplant red cells following Rh-incompatible bone marrow transplantationM U Heim, M Schleuning, R Eckstein, et al.
Bone Marrow Transplantation|August 1, 1990
Soluble interleukin 2 receptors in patients after bone marrow transplantationW Siegert, O Josimovic-Alasevic, R Schwerdtfeger, et al.
Clinical Pharmacology and Therapeutics|January 1, 1995
Pharmacodynamics of daily subcutaneous recombinant human interleukin-3 in normal volunteersR D Huhn, E J Yurkow, J G Kuhn, et al.
Experimental Hematology|December 1, 1993
Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cellsI G Schmidt-Wolf, P Lefterova, B A Mehta, et al.
Blut|March 1, 1988
German-Austrian multicenter trial for aggressive non-Hodgkin lymphomas: COP-BLAM/IMVP-16 chemotherapy with randomized adjuvant radiotherapyH H Gerhartz, E Thiel, G Brittinger, et al.
The Journal of Organic Chemistry|January 27, 2007
Synthesis of pyrazolo[1,5-alpha]pyrimidinone regioisomersLori K Gavrin, Arthur Lee, Brian A Provencher, et al.
British Journal of Haematology|October 16, 1999
Efficacy and toxicity of IFN-alpha2b combined with cytarabine in chronic myelogenous leukaemiaM Lindauer, D Domkin, H Döhner, et al.
Blood|February 7, 1998
Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemiasM Schmidt, S Nagel, J Proba, et al.
Pageof 38